BE881209A - Composition pharmaceutique pour lutter contre le taux de croissance des tumeurs et methode d'utilisation de celle-ci - Google Patents
Composition pharmaceutique pour lutter contre le taux de croissance des tumeurs et methode d'utilisation de celle-ciInfo
- Publication number
- BE881209A BE881209A BE0/199012A BE199012A BE881209A BE 881209 A BE881209 A BE 881209A BE 0/199012 A BE0/199012 A BE 0/199012A BE 199012 A BE199012 A BE 199012A BE 881209 A BE881209 A BE 881209A
- Authority
- BE
- Belgium
- Prior art keywords
- pharmaceutical composition
- same
- tumor growth
- growth rate
- controlling tumor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81476577A | 1977-07-11 | 1977-07-11 | |
US2875779A | 1979-04-10 | 1979-04-10 | |
US2875879A | 1979-04-10 | 1979-04-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE881209A true BE881209A (fr) | 1980-05-16 |
Family
ID=27363337
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE189191A BE868882A (fr) | 1977-07-11 | 1978-07-10 | Derives halogenomethyles d'alpha-aminoacides, leur preparation et leurs utilisations therapeutiques |
BE0/199011A BE881208A (fr) | 1977-07-11 | 1980-01-17 | Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ci |
BE0/199012A BE881209A (fr) | 1977-07-11 | 1980-01-17 | Composition pharmaceutique pour lutter contre le taux de croissance des tumeurs et methode d'utilisation de celle-ci |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE189191A BE868882A (fr) | 1977-07-11 | 1978-07-10 | Derives halogenomethyles d'alpha-aminoacides, leur preparation et leurs utilisations therapeutiques |
BE0/199011A BE881208A (fr) | 1977-07-11 | 1980-01-17 | Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ci |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS5419913A (fr) |
AU (1) | AU522660B2 (fr) |
BE (3) | BE868882A (fr) |
CA (1) | CA1091661A (fr) |
CH (1) | CH642055A5 (fr) |
DE (1) | DE2828739A1 (fr) |
FR (1) | FR2430418A1 (fr) |
GB (1) | GB2001960B (fr) |
NL (2) | NL190662C (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0326766A1 (fr) * | 1988-02-05 | 1989-08-09 | Merrell Dow Pharmaceuticals Inc. | Dérivés 5-substitués d'ornithine |
EP0228034A3 (en) * | 1985-12-19 | 1990-05-09 | Merrell Dow Pharmaceuticals Inc. | Arginine and agmatine derivatives for treating protozoal infections |
US6103220A (en) * | 1998-01-23 | 2000-08-15 | Levine; Martin | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
US6187296B1 (en) | 1998-01-23 | 2001-02-13 | The Board Of Regents Of The University Of Oklahoma | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1174603A (fr) | 1980-06-16 | 1984-09-18 | Albert Sjoerdsma | Methode pour inhiber la croissance de protozoaires |
US4399151A (en) | 1980-06-16 | 1983-08-16 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting the growth of protozoa |
GB2083030B (en) * | 1980-08-23 | 1984-03-07 | Merrell Toraude & Co | Fluorinated pentene diamine derivatives |
ZA815808B (en) * | 1980-08-23 | 1982-08-25 | Merrell Toraude & Co | Fluorinated pentene diamine derivatives |
US4437873A (en) | 1981-03-23 | 1984-03-20 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting algae |
US4446151A (en) * | 1981-08-19 | 1984-05-01 | Merrell Toraude Et Compagnie | Decarboxylase-inhibiting fluorinated pentane diamine derivatives |
US4423073A (en) * | 1981-08-19 | 1983-12-27 | Merrell Toraude Et Compagnie | Fluorinated diaminopentene derivatives |
US4435425A (en) | 1982-04-09 | 1984-03-06 | Merrell Toraude Et Compagnie | Fluorinated diaminobutane derivatives |
CA1319123C (fr) * | 1988-08-31 | 1993-06-15 | Andrew T. Au | Methode de preparation de (-)-derives de substitution en 2 d'ornithines |
US7015349B2 (en) | 2003-03-26 | 2006-03-21 | The Gillette Company | Reduction of hair growth |
WO2021209563A1 (fr) | 2020-04-16 | 2021-10-21 | Som Innovation Biotech, S.A. | Composés destinés à être utilisés dans le traitement d'infections virales par un coronavirus associé au syndrome respiratoire |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ187377A (en) * | 1977-06-01 | 1981-05-15 | Merck & Co Inc | A-amino-a-substituted alkyl-a-fluoromethylacetic acids |
-
1978
- 1978-06-07 CA CA304,918A patent/CA1091661A/fr not_active Expired
- 1978-06-21 AU AU37327/78A patent/AU522660B2/en not_active Expired
- 1978-06-27 GB GB7827967A patent/GB2001960B/en not_active Expired
- 1978-06-30 DE DE19782828739 patent/DE2828739A1/de active Granted
- 1978-07-10 CH CH746678A patent/CH642055A5/de not_active IP Right Cessation
- 1978-07-10 FR FR7820517A patent/FR2430418A1/fr active Granted
- 1978-07-10 BE BE189191A patent/BE868882A/fr not_active IP Right Cessation
- 1978-07-11 NL NL7807453A patent/NL190662C/xx not_active IP Right Cessation
- 1978-07-11 JP JP8361978A patent/JPS5419913A/ja active Granted
-
1980
- 1980-01-17 BE BE0/199011A patent/BE881208A/fr not_active IP Right Cessation
- 1980-01-17 BE BE0/199012A patent/BE881209A/fr not_active IP Right Cessation
-
1995
- 1995-11-17 NL NL950027C patent/NL950027I2/nl unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0228034A3 (en) * | 1985-12-19 | 1990-05-09 | Merrell Dow Pharmaceuticals Inc. | Arginine and agmatine derivatives for treating protozoal infections |
EP0326766A1 (fr) * | 1988-02-05 | 1989-08-09 | Merrell Dow Pharmaceuticals Inc. | Dérivés 5-substitués d'ornithine |
US6103220A (en) * | 1998-01-23 | 2000-08-15 | Levine; Martin | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
US6187296B1 (en) | 1998-01-23 | 2001-02-13 | The Board Of Regents Of The University Of Oklahoma | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
Also Published As
Publication number | Publication date |
---|---|
CH642055A5 (de) | 1984-03-30 |
GB2001960A (en) | 1979-02-14 |
GB2001960B (en) | 1982-02-24 |
JPH0122259B2 (fr) | 1989-04-25 |
NL7807453A (nl) | 1979-01-15 |
BE881208A (fr) | 1980-05-16 |
NL190662B (nl) | 1994-01-17 |
NL190662C (nl) | 1994-06-16 |
JPS5419913A (en) | 1979-02-15 |
FR2430418A1 (fr) | 1980-02-01 |
FR2430418B1 (fr) | 1984-07-13 |
AU522660B2 (en) | 1982-06-17 |
AU3732778A (en) | 1980-01-03 |
DE2828739A1 (de) | 1979-02-01 |
NL950027I1 (nl) | 1996-02-01 |
BE868882A (fr) | 1978-11-03 |
NL950027I2 (nl) | 1997-06-02 |
CA1091661A (fr) | 1980-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE881209A (fr) | Composition pharmaceutique pour lutter contre le taux de croissance des tumeurs et methode d'utilisation de celle-ci | |
GB2006181B (en) | Growth of biological material | |
NZ195703A (en) | Treatment and control of mastitis and compositions therefor | |
PH15877A (en) | Novel n-heterocyclyl-4-piperidiamines,pharmaceutical composition containing same and method of use | |
IL55429A0 (en) | Thiadiaolyl cephalosporin analogs, processes for the preparation thereof,pharmaceutical or veterinary compositions containing the same and method of inhibiting the growth of bacteria therewith | |
PH18091A (en) | Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof | |
DE3176062D1 (en) | Process and apparatus for controlling cultivation of microorganisms | |
RO80669A (fr) | Composition pour la croissance du cheveu et procede d'obtention | |
BE881550A (fr) | Melange de stereoisomeres de 2-(4-chlorophenyl)-isovalerate d'alpha-cyano-3-(4-halogenophenoxy)-benzyle, son procede de preparation et composition en contenant | |
PT79485B (en) | Process for preparing oxazolidines and of pharmaceutical compositions containing the same | |
IL54501A (en) | N-(trifluoromethanesulphonamidophenyl)-n-heterocyclic compounds,their preparation and their use for regulation of plant growth | |
DE3069698D1 (en) | Process and apparatus for accelerating growth rate of salmonoids and other fish and the like | |
DE3173499D1 (en) | Novel thioesters and process for the preparation of the same | |
GB2105992B (en) | Pharmaceutical composition for treatment of cardio-vascular diseases | |
RO80699A (fr) | Procede pour la preparation des 3-phenyl-4(1h)-piridinthiones | |
ZA83918B (en) | Process and composition for controlled nourishing of agricultural plants | |
PH17057A (en) | Kijanimicin and salts thereof,pharmaceutical compositions containing same and process of preparring same | |
LU79426A1 (fr) | Compositions purifiees d'urokinase et procede pour leur obtention | |
PT68556A (fr) | Procede pour regler l'accroissement des plantes contenant-des composes azotes policicliques | |
PT74849A (en) | Process for preparing new substituted 3-(parasubstituted) phenoxy-1-alkylamino-propanol-2-s and of pharmaceutical compositions containing the same | |
GB2085008B (en) | 1,5-bis-(2,3-dihydro-1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application | |
PT76951B (en) | Process for the preparation of racemic or optically active eburnane-oxime derivatives and pharmaceutical compositions containing them | |
ZA836932B (en) | Heterocyclic compounds,their preparation,compositions containing them and method of controlling unwanted plant growth | |
JPS561816A (en) | Waste straw dropping apparatus of combine | |
JPS5751196A (en) | Melt for growing single crystal of magnetoplumbite and single crystal growth of magnetoplumbite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE20 | Patent expired |
Owner name: MERREL TORAUDE ET CIE Effective date: 20000117 |